Diff for "Cytoscape_3/CoreDevelopment"

Differences between revisions 8 and 10 (spanning 2 versions)

Cytoscape 3.0 Core Developer Documentation

This documentation provides much of the low-level detail needed to understand Cytoscape 3.0 Core development.

Cytoscape_3/CoreDevelopment (last edited 2016-07-14 18:16:22 by AlexPico)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

-  ← Revision 8 as of 2011-03-03 16:58:47 →
  Size: 500
  Editor: alsace
  Comment:
+  ← Revision 10 as of 2011-09-01 21:40:14 →
  Size: 400
  Editor: alsace
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 1:
+= Cytoscape 3.0 Core Developer Documentation =

This documentation provides much of the low-level detail needed to understand Cytoscape 3.0 Core development.
-Line 2:
+Line 4:
-== Purpose ==

Here documentation is about the development of the Cytoscape core.

Quite some documentation concerning the development process of Cytoscape 3 is under the [[Outdated_Cytoscape_3.0|outdated pages]]. 



== Cytoscape 3: Motivation ==
+ * [[/Architecture|Cytoscape 3 Architecture]]
-Line 8:
+Line 6:
-== Architecture ==

 * [[/Architecture|Cytoscape 3 Architecture]] 



== API ==
-Line 14:
+Line 7:
-== Debugging ==
-Line 17:
+Line 8:
+ * [[/AutomatedTesting|Automated Testing]]